Post-approval studies (Phase 4)WithdrawnNCT00396240
What this trial is testing
ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals
Who this might be right for
Primary Hypercholesterolaemia
AstraZeneca 1,294